DMU-212 against EGFR-mutant non-small cell lung cancer via AMPK/PI3K/Erk signaling pathway

Although some important advances have been achieved in clinical and diagnosis in the past few years, the management of non-small cell lung cancer (NSCLC) is ultimately dissatisfactory due to the low overall cure and survival rates. Epidermal growth factor (EGFR) has been recognized as a carcinogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xiao-Ping, Zheng, Xiao-Li, Huang, Min, Xie, Ya-Jia, Nie, Xiao-Wen, Nasim, Ali Adnan, Yao, Xiao-Jun, Fan, Xing-Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256861/
https://www.ncbi.nlm.nih.gov/pubmed/37305501
http://dx.doi.org/10.1016/j.heliyon.2023.e15812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256861/
https://www.ncbi.nlm.nih.gov/pubmed/37305501
http://dx.doi.org/10.1016/j.heliyon.2023.e15812

Ejemplares similares